PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Metrics, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Metrics, Inc. Names Wes Edwards, MBA, CPA As Chief Financial Officer - Edwards will oversee the company's financial, logistical and human-resources operations - MetricsInc.com
Metrics, Inc. Names Wes Edwards, MBA, CPA As Chief Financial Officer

 

NewswireToday - /newswire/ - Greenville, NC, United States, 2013/08/01 - Edwards will oversee the company's financial, logistical and human-resources operations - MetricsInc.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Contract pharmaceutical developer and manufacturer Metrics Inc. has appointed Wes Edwards, MBA, CPA, as its chief financial officer.

Edwards who brings to Metrics 15 years of corporate and military experience in finance, accounting, supply chain management and pricing will oversee all of the company’s financial, logistical and human-resources operations.

Last year, the privately held Metrics was acquired by Mayne Pharma Group Limited, a corporation publicly traded on the Australian Securities Exchange (ASX). Going public means Metrics now interacts with newfound stakeholders such as regulators and investors who have clear expectations when it comes to financial disclosure, said Phil Hodges, president of Metrics Inc.

“Wes has significant expertise when it comes to operating in public companies along with a deep appreciation for organizational integrity and performance which makes his coming onboard at Metrics timely and useful,” Hodges said. “I know he’ll apply his knowledge in ways that help protect the company’s assets and deliver superior financial results.”

Before joining Metrics, Edwards was the controller and finance director of two affiliated divisions of MBM Customized Foodservice Distribution. While there, the company was acquired by McLane Company Inc., part of the famed holding company, Berkshire Hathaway, owned by billionaire Warren Buffett.

During his tenure at MBM, Edwards was responsible for a team of finance, accounting and information technology professionals supporting all aspects of financial analysis and execution, cash and risk management, internal control and external general accepted accounting principles (GAAP) compliance.

Prior to that, Edwards was a senior finance analyst with Procter & Gamble, where he managed the budgets and supply chains for the $186-million Gillette and P & G antiperspirant product lines.

His move into corporate finance followed five years of service in the U.S. Air Force, where he managed finances for both the Delta IV rocket’s satellite launch services program and the B-1 bomber’s weapons modifications program, and attained the rank of captain.

Edwards earned his master’s in business administration degree from The Ohio State University’s Fisher School of Business. He attended the University of North Carolina at Chapel Hill on an ROTC scholarship, graduating with a bachelor’s degree in economics. Edwards is a certified public accountant.

Metrics Inc. is a full-service global pharmaceutical development and manufacturing organization serving clients worldwide. We deliver proven scientific and operational excellence for solid oral dosage forms.

Our company’s areas of expertise include quality pharmaceutical formulation development; first-time-in-man (FTIM) formulations; clinical trial material (CTM) manufacturing for Phase I, II and III trials; and analytical method development and validation services leading to commercial scale manufacturing.

Within the past five years, Metrics (metricsinc.com) has conducted more than 75 FTIM studies while simultaneously producing 700-plus batches of CTM.

Metrics’ technical capabilities include highly potent, cytotoxic and unstable compounds, Schedule II-V controlled substances, and products with poor bioequivalence for which we offer an impressive proprietary portfolio of advanced delivery methods.

Our work supports investigational new drug (IND), new drug (NDA) and abbreviated new drug (ANDA) submissions made to worldwide regulatory agencies on behalf of clients ranging from internationally renowned corporations to small virtual companies.

Based in Greenville, N.C., Metrics Inc. proudly operates as a subsidiary of Mayne Pharma Group Limited.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Metrics, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Metrics, Inc. Names Wes Edwards, MBA, CPA As Chief Financial Officer

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Metrics, Inc. | Wes Edwards CFO
Publisher Contact: Karen Stinneford - Sinclair-Co.com for Metrics 
919-833-9102 kys[.]sinclair-co.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Metrics, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Metrics, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  1Click Games

Visit  Intrinsic Executive Search Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)